HCV-IN-4 是一种有效、可口服的 HCV NS5A 抑制剂，可抑制 GT1a，GT2b，GT3a，GT1a Y93H 和 GT1a L31V 的增殖，EC90 值分别为 3 pM，0.3 nM，0.01 nM，0.5 nM 和 0.02 nM。
CAS：2058080-25-2
分子式：C52H58FN9O8
分子量：956.07
纯度：98%
存储：Store at -20°C

Background:

HCV-IN-4 is a potent and orally active HCV NS5A inhibitor, shows great potency against GT1a, GT2b, GT3a, GT1a Y93H and GT1a L31V, with EC90s of 3 pM, 0.3 nM, 0.01 nM, 0.5 nM and 0.02 nM, respectively[1]. EC90: 3 pM (GT1a), 0.3 nM (GT2b), 0.01 nM (GT3a), 0.5 nM (GT1a Y93H), 0.02 nM (GT1a L31V)[1]

[1]. Yu W, et al. Discovery of Chromane Containing Hepatitis C Virus (HCV) NS5A Inhibitors with Improved Potency against Resistance-Associated Variants. J Med Chem. 2016 Nov 23;59(22):10228-10243. Epub 2016 Nov 9.